AstraZeneca to transfer rights for Eklira and Duaklir to Covis Pharma
The two medicines are delivered via a breath-actuated multi-dose dry powder inhaler, Genuair
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Nov 21
The two medicines are delivered via a breath-actuated multi-dose dry powder inhaler, Genuair
01 Nov 21
The US regulator has indicated Pfizer-BioNTech Covid-19 vaccine, also called Comirnaty, in a two-dose regimen of 10µg doses…
01 Nov 21
Also known as a STAMP inhibitor, Scemblix is the first FDA-approved CML treatment that works by binding to…
28 Oct 21
Merck, Ridgeback and Emory University will not receive royalties for sales of molnupiravir as long as the WHO…
28 Oct 21
Novartis’ filing was supported by the ELARA trial, which showed that treatment using Kymriah resulted in superior response…
27 Oct 21
The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) reviewed the data, and voted 17 to 0,…
27 Oct 21
The regimen includes Merck’s nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s potential capsid inhibitor lenacapavir
26 Oct 21
The Phase 3 CANOPY-1 study did not meet its primary endpoints of OS and PFS in patients with…
26 Oct 21
In the Phase 2/3 study, two 50μg doses of mRNA-1273 were generally well tolerated and showed superior neutralising…
25 Oct 21
Susvimo, earlier known as Port Delivery System with ranibizumab, is said to be the first and only FDA-approved…